Pipecuronium Bromide Hydrate

哌库溴铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePipecuronium Bromide Hydrate
Drug Alias Name泮库溴铵水合物bromuro de pipecuroniopipecuronii bromidumArduanRGH-1106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsMuscle relaxation agents
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsHyperemesis GravidarumAnesthesia
Global Approved IndicationsHyperemesis GravidarumAnesthesia
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryUnited States
Original Approved Date1990/06/26
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganon Usa Inc
Active IndicationsHyperemesis Gravidarum
Inactive IndicationsAnesthesia

Other Information

ATC CodeM03AC06